Liberals accused of caving on drug ‘concession’ at request of U.S.
by from on (#40628)
The proposed United States-Mexico-Canada Agreement extends a so-called "market exclusivity" period for biologic drugs - used in some Crohn's and cancer treatments - to 10 years from eight.